CUBIST PHARMACEUTICALS INC's ticker is CBST and the CUSIP is 229678107. A total of 253 filers reported holding CUBIST PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $665,000 | +20.5% | 10,020 | +26.7% | 0.18% | +16.2% |
| Q2 2014 | $552,000 | +21.9% | 7,910 | +27.5% | 0.15% | +6.9% |
| Q1 2014 | $453,000 | +5.8% | 6,205 | -0.2% | 0.14% | -4.0% |
| Q4 2013 | $428,000 | -46.2% | 6,215 | -50.3% | 0.15% | -52.8% |
| Q3 2013 | $795,000 | +17.6% | 12,510 | -10.6% | 0.32% | +5.0% |
| Q2 2013 | $676,000 | – | 13,995 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AKANTHOS CAPITAL MANAGEMENT LLC | 50,500 | $3,526,000 | 10.49% |
| Palo Alto Investors LP | 1,526,916 | $106,609,000 | 7.94% |
| HealthCor Management, L.P. | 1,225,000 | $85,530,000 | 4.29% |
| SECTOR GAMMA AS | 192,490 | $13,440,000 | 3.18% |
| AMI ASSET MANAGEMENT CORP | 363,698 | $25,393,000 | 2.52% |
| EAGLE BOSTON INVESTMENT MANAGEMENT INC | 578,207 | $40,370,000 | 2.01% |
| TURNER INVESTMENTS LLC | 559,239 | $39,046,000 | 1.73% |
| Tekla Capital Management LLC | 263,772 | $18,417,000 | 1.69% |
| MAZAMA CAPITAL MANAGEMENT INC | 80,221 | $5,601,000 | 1.50% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 3,234,570 | $225,838,000 | 1.34% |